Febre reumática: revisão e discussão dos novos critérios diagnósticos
Conteúdo do artigo principal
Resumo
Objetivo: A febre reumática é uma doença que ainda contempla grandes dificuldades em seu diagnóstico. Provoca graves sequelas que perduram por toda a vida do indivíduo com alto custo pessoal e para a saúde pública. Nosso objetivo é discutir os novos critérios diagnósticos publicados pela American Heart Association em 2015, revisando a literatura sobre a doença. Fonte de dados: Revisão com base em busca de artigos com a palavra-chave “febre reumática” em português, inglês ou espanhol, em plataformas de artigos Medline, PubMed e Scielo sem limitação de data. Síntese dos dados: Os novos critérios diagnósticos publicados pela American Heart Association em 2015 propõem categorizar a apresentação da doença conforme a identificação das populações em alto, moderado e baixo risco e estipula a conduta perante a esses diversos tipos de pacientes. Conclusão: Nos países em desenvolvimento, como o Brasil, onde a desigualdade socioeconômica entre populações é um problema reconhecido, essa nova categorização pode auxiliar na melhor condução diagnóstica e terapêutica da doença.
Downloads
Detalhes do artigo
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Referências
1. Taranta A, Markowitz M. Definições, historia e geografia. In: Taranta, A, Markowitz, M, editors. A febre reumática. Lancaster, Kluwer Academic Publshers; 1989. p. 1-10.
2. Taranta, A., Markowitz, M. Diagnósticos. In: Taranta, A, Markowitz, M, editors. A febre reumática. Lancaster, Kluwer Academic Publshers; 1989. p. 50-5.
3. Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010 Sep;126(3):e557-64.
4. Ralph A, Jacupus S, McGough K, McDonald M, Currie BJ. The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed guidelines for diagnosis in Australia’s Northern Territory. Heart Lung Circ 2006 Apr;15(2):113-8.
5. Shetty A, Mills C, Eggleton K. Primary care management of group A streptococcal pharyngitis in Northland. J Prim Health Care. 2014 Sep 1;6(3):189-94.
6. Taranta A, Markowitz M. Etiologia e epidemiologia. In: Taranta, A, Markowitz, M, editors. A febre reumática. Lancaster, Kluwer Academic Publshers; 1989. p. 11-9.
7. Lee JL, Nagura SM, Cheema GS, Gershwin ME. Acute rheumatic fever and its consequences: A persistent threat to developing nations in the 21st century. Autoimmun Rev. 2009 Dec 9(2):117-23.
8. Carapetis JR, Steer AC, Mulholaand EK, Weber M. The global burden of group A Steptococcal diseases. Lancet Infect Dis. 2005 Nov;5(11):685-94.
9. Martin WJ, Steer AC, Smeesters PR, Keeble J, Inouye M, Carapetis J, Wicks IP. Post-infections group A streptococcal autoimmune syndromes and the heart. Autoimmun Rev. 2015 Aug;14(8):710-25.
10. Catarino SJ, Boldt AB, Beltrame MH, Nisihara RM, Schafranski MD, de Messias-Reason IJ. Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease. Hum Immunol. 2014 Dec 75(12):1197-202.
11. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical Validation of Guidelines for the Management of
Pharyngitis in Children and Adults. JAMA. 2004 Apr 7;291(13):1587-95.
12. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency
room. Med Decis Making 1981;1(3):239-46.
13. Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012 Jun 11;172(11):847-52.
14. Wyber R, Zühlke L, Carapetis J. The case for global investment in rheumatic heart-disease control. Bull World Health Organ. 2014 Oct 1;92(10):768-70.
15. Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, Remenyi B, Taubert KA, Bolger AF, Beerman L, Mayosi BM, Beaton A, Pandian NG, Kaplan EL; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015 May 19;131(20):1806-18.
16. Markham R, Tulloh R. Fifteen-minute consultation: rheumatic fever. Arch Dis Child Educ Pract Ed. 2015 Aug;100(4):176-9
17. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012 Mar 10;379(9819):953-64.
18. Kumar R, Sharma YP, Thakur JS, Patro BK, Bhatia A, Singh IP, et al. Streptococcal pharyngitis, rheumatic fever and rheumatic heart disease: Eight-year prospective surveillance in Rupnagar district of Punjab, India. Natl Med J India. 2014 Mar-Apr;27(2):70-5.
19. Walker KG, de Vries PJ, Stein DJ, Wilmshurst JM. Sydenham Chorea and PANDAS in South Africa: Review of Evidence and Recommendations for Management in Resource-Poor Countries. J Child Neurol. 2015 Jun;30(7):850-9.
20. Sociedade Brasileira de Cardiologia. Diretrizes brasileiras para o diagnóstico, tratamento e prevenção da febre reumática. Arq. bras. Cardiol. 2009 Set 93(3,supl.4):3-18.
21. Peebles TC. Identification and treatment of group A beta-hemolytic streptococcal infections. Role of the pediatrician and the nurse-practitioner. Pediatr Clin North Am. 1971 Feb;18(1):145-58.
22. Guilherme L, Postol E, Ferreira FM, DeMarchi LMF, Kalil J. StreptInCor: a model of anti-Streptococcus pyogenes vaccine reviewed Auto Immun Highlights. 2013 Oct 4;4(3):81-5.
23. Radcliff FJ, Fraser JD, Proft T. Vaccination with Streptococcus pyogenes nuclease A stimulates a high antibody response but no protective immunity in a mouse model of infection. Med Microbiol Immunol. 2015 Apr;204(2):185-91.
24. Mocumbi AO. Rheumatic Heart disease in
Africa: is there a role for genetic studies?
Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl
1):S21-6.
25. Lennon D, Stewart J. An important investment to control Acute Rheumatic Fever needs to run its course. N Z Med J. 2015 Jun 12;128(1416):6-9.
26. Thompson SB, Brown CH, Edwards AM, Lindo JL. Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica. Pathog Glob Health. 2014 Jul 108(5):229-34.
27. Mirabel M, Fauchier T, Bacquelin R, Tafflet M, Germain A, Robillard C, et al. Echocardiography screening to detect
rheumatic heart disease: A cohort study of schoolchildren in French Pacific Islands. Int J Cardiol. 2015 Jun 1;188:89-95.
28. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol. 2012 Feb 28;9(5):297-309.
29. Zachariah JP, Samnaliev M. Echo-based screeening of rheumatic heart disease in children: a cost effectiveness. J Med Econ. 2015 Jun 18(6):410-9.
30. Zühlke L, Engel ME, Lemmer CE, van de Wall M, Nkepu S, Meiring A, et al. The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study. BMC Cardiovasc Disord. 2016 Feb 19;16(1):46.